• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类微生物群与癌症化疗的疗效。

Human microbiota and effectiveness of cancer chemotherapy.

机构信息

NSC "Institute of Biology and Medicine" of Taras Shevchenko National University of Kyiv, Kyiv 01033,Ukraine.

RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NASU, Kyiv 03022, Ukraine.

出版信息

Exp Oncol. 2020 Jun;42(2):82-93. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14611.

DOI:10.32471/exp-oncology.2312-8852.vol-42-no-2.14611
PMID:32602287
Abstract

This review presents up-to-date information on the effects of microbiota on the individual chemotherapy sensitivity in cancer treatment. Recent studies have shown that a fine balance between the intestinal microbiota and the immune system is crucial for maintaining an efficacy of cancer chemotherapy. A number of antitumor drugs have complex mechanisms of action involving not only direct effects but also the activity of the intestinal microbiota and the immune system. A unique combination of these factors contributes to the individual chemotherapy sensitivity.

摘要

这篇综述介绍了关于肠道微生物群对癌症治疗中个体化疗敏感性影响的最新信息。最近的研究表明,肠道微生物群和免疫系统之间的微妙平衡对于维持癌症化疗的疗效至关重要。许多抗肿瘤药物的作用机制复杂,不仅涉及直接作用,还涉及肠道微生物群和免疫系统的活性。这些因素的独特组合导致了个体化疗敏感性的差异。

相似文献

1
Human microbiota and effectiveness of cancer chemotherapy.人类微生物群与癌症化疗的疗效。
Exp Oncol. 2020 Jun;42(2):82-93. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14611.
2
Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.Toll样受体在化疗诱导的胃肠道毒性发病机制中的作用
Curr Opin Support Palliat Care. 2016 Jun;10(2):157-64. doi: 10.1097/SPC.0000000000000202.
3
The impact of modulating the gastrointestinal microbiota in cancer patients.调节癌症患者的胃肠道微生物群的影响。
Best Pract Res Clin Gastroenterol. 2020 Oct-Dec;48-49:101700. doi: 10.1016/j.bpg.2020.101700. Epub 2020 Oct 19.
4
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.肠道微生物群与癌症:肠道微生物群如何调节抗肿瘤治疗的活性、疗效和毒性。
Crit Rev Oncol Hematol. 2019 Nov;143:139-147. doi: 10.1016/j.critrevonc.2019.09.003. Epub 2019 Sep 20.
5
[The role of intestinal microbiota in the response to anti-tumor therapies].[肠道微生物群在抗肿瘤治疗反应中的作用]
Med Sci (Paris). 2016 Nov;32(11):974-982. doi: 10.1051/medsci/20163211013. Epub 2016 Dec 23.
6
Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities.化疗相关行为合并症中的肠道微生物群-免疫-大脑相互作用。
Cancer. 2018 Oct 15;124(20):3990-3999. doi: 10.1002/cncr.31584. Epub 2018 Jul 5.
7
[Gut microbiota and efficacy of cancer therapies].[肠道微生物群与癌症治疗的疗效]
Biol Aujourdhui. 2017;211(1):51-67. doi: 10.1051/jbio/2017009. Epub 2017 Jul 6.
8
Relationship Between the Gut Microbiome and Systemic Chemotherapy.肠道微生物组与全身化疗的关系。
Dig Dis Sci. 2020 Mar;65(3):874-884. doi: 10.1007/s10620-020-06119-3.
9
Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice.盐酸千金藤碱通过调节小鼠肠道微生物改善顺铂化疗并增强免疫。
Front Cell Infect Microbiol. 2019 Jun 26;9:225. doi: 10.3389/fcimb.2019.00225. eCollection 2019.
10
Gut microbiota modulation of chemotherapy efficacy and toxicity.肠道微生物群调节化疗疗效和毒性。
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):356-365. doi: 10.1038/nrgastro.2017.20. Epub 2017 Mar 8.

引用本文的文献

1
Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment.微生物群在肺癌中的作用:预防和治疗的新视角。
Int J Mol Sci. 2022 May 30;23(11):6138. doi: 10.3390/ijms23116138.
2
Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients.鉴定新型癌症微生物组特征,预测人类乳腺癌患者的预后。
Clin Transl Oncol. 2022 Mar;24(3):597-604. doi: 10.1007/s12094-021-02725-3. Epub 2021 Nov 6.
3
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.宿主遗传学与肠道微生物组:多发性硬化症的展望。
Genes (Basel). 2021 Jul 29;12(8):1181. doi: 10.3390/genes12081181.